Is Amrutanjan Health Care the Best Stock in Its Sector? A Look at the Numbers

Amrutanjan Health Care CMP Rs 500 (23 Sep 2026). Market cap Rs 1,446 Cr. ROE 17.42%. P/E 26.79x versus Industry P/E 51.81x.

Updated: 23 Sept 2026 • 10:01 am

Posted by:

Is Amrutanjan Health Care the Best Stock in Its Sector? A Look at the Numbers

Quick Answer

Amrutanjan Health Care is one of the names investors compare when screening the FMCG sector, built on a 17.42% return on equity and a P/E of 26.79x against an Industry P/E of 51.81x. Whether Amrutanjan Health Care is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named FMCG sector peers, so you can judge that for yourself.

Is Amrutanjan Health Care the best stock in its sector? The stock trades on the NSE at Rs 500 as of 23 September 2026, within its 52-week range of Rs 476.50 to Rs 772.00. Amrutanjan Health Care Ltd markets pain relief balms and over-the-counter healthcare products under the Amrutanjan brand.

Amrutanjan Health Care sits in the FMCG sector, and its 17.42% ROE and 26.79x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector's Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

Table of Contents

About Amrutanjan Health Care

Amrutanjan Health Care Ltd markets pain relief balms and over-the-counter healthcare products under the Amrutanjan brand. It markets pain relief balms and over-the-counter healthcare products under the Amrutanjan brand, one of India's oldest established pain relief brands. At a market capitalisation of Rs 1,446 Cr, it is tracked as part of the FMCG sector on Univest.

Is Amrutanjan Health Care the Best Stock in Its Sector?

Amrutanjan Health Care makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 17.42% ROE with a 26.79x P/E against the sector's 51.81x Industry P/E. Amrutanjan Health Care's 26.79x P/E is well below the 51.81x Industry P/E despite a 17.42% ROE ahead of Dabur India's in this comparison, making it look inexpensive relative to its own quality among FMCG peers.

Metric	Amrutanjan Health Care
CMP (NSE)	Rs 500.05
52-Week High / Low	Rs 772.00 / Rs 476.50
Market Cap	Rs 1,446 Cr
P/E (TTM) vs Industry P/E	26.79x vs 51.81x
P/B	3.91
ROE	17.42%
EPS (TTM)	Rs 18.67
Dividend Yield	0.98%
Debt to Equity	0.00

Compare Amrutanjan Health Care Against Other FMCG Sector Stocks

How Amrutanjan Health Care Compares Against Its FMCG Sector Peers

The table below sets Amrutanjan Health Care against 3 other FMCG sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 3 peer companies.

Company	Market Cap (Rs Cr)	P/E	ROE	Debt to Equity
Amrutanjan Health Care	1,446	26.79	17.42%	0.00
Dabur India	66,789	34.32	16.59%	0.11
Marico	1,04,535	53.56	41.85%	0.13
Jyothy Labs	7,067	24.90	20.97%	0.03
Peer average (3 companies)	-	37.59	26.47%	0.09

Against this peer set, Amrutanjan Health Care's 17.42% ROE is below the 26.47% peer average, and its P/E of 26.79x runs below the peer average of 37.59x. Amrutanjan Health Care's 26.79x P/E is well below the 51.81x Industry P/E despite a 17.42% ROE ahead of Dabur India's in this comparison, making it look inexpensive relative to its own quality among FMCG peers.

What Makes Amrutanjan Health Care Worth Watching in FMCG

Well below Industry P/E: A 26.79x P/E against a 51.81x Industry P/E is a significant discount for a business with a 17.42% ROE.
Debt free balance sheet: A debt to equity ratio of 0.00 gives Amrutanjan Health Care complete flexibility to fund brand marketing and distribution.
Established pain relief brand: Decades of brand recognition in pain relief balms give Amrutanjan pricing power and shelf presence across India.

Amrutanjan Health Care Valuation: Is It Justified?

Amrutanjan Health Care's 26.79x P/E is well below the 51.81x Industry P/E despite a 17.42% ROE ahead of Dabur India's in this comparison, making it look inexpensive relative to its own quality among FMCG peers. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Allied Blenders and Distillers the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track Amrutanjan Health Care and other FMCG sector stocks.

How to Track Amrutanjan Health Care Before You Invest

Before deciding whether Amrutanjan Health Care deserves its label as the best stock in its sector for your own portfolio, compare it directly against FMCG sector peers using the steps below.

Open the Univest Screener and search for Amrutanjan Health Care to view live price, valuation ratios, and peer comparisons within the FMCG sector.
Compare its P/E, P/B, and ROE against other FMCG sector stocks before deciding if the current valuation fits your strategy.
Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Amrutanjan Health Care earns a place in the best stock in its sector conversation on the strength of a 17.42% ROE and a P/E of 26.79x against a 51.81x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Is Amrutanjan Health Care the best stock in its sector?

Ans. Amrutanjan Health Care has a 17.42% ROE and trades at 26.79x P/E against a 51.81x Industry P/E, and compares below the peer average ROE of 26.47% in this article's named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of Amrutanjan Health Care?

Ans. Amrutanjan Health Care was trading at Rs 500.05 on the NSE as of 23 September 2026, within its 52-week range of Rs 476.50 to Rs 772.00.

What sector does Amrutanjan Health Care belong to?

Ans. Amrutanjan Health Care is classified under the FMCG sector on Univest.

How does Amrutanjan Health Care compare to its sector peers on P/E?

Ans. Amrutanjan Health Care's P/E of 26.79x is below the 37.59x average of the 3 named peers compared in this article.

What is Amrutanjan Health Care's return on equity?

Ans. Amrutanjan Health Care reported a return on equity of 17.42%, which is below the 26.47% average of its named peers in this comparison.

Should I invest in Amrutanjan Health Care based on its sector position?

Ans. Amrutanjan Health Care's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.